CONMED CFO Todd Garner To Step Down Effective March 15, 2026; Co. Reaffirms Full-Year 2025 Revenue and Adjusted EPS Outlook

CONMED Corporation (NYSE:CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026.

CONMED has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next Chief Financial Officer.

"On behalf of our Board and leadership team, I want to thank Todd for his many contributions to CONMED over the past eight years," said Pat Beyer, President and Chief Executive Officer. "Todd has been instrumental in strengthening our financial foundation and supporting strategic initiatives that position CONMED for scalable, long-term growth. We are also grateful for his commitment to ensuring a seamless transition."

"I am grateful to my CONMED colleagues over the past eight years. It has been rewarding to be part of such a high-quality, driven team that has dramatically improved the revenue growth and profitability of the company. I'm committed to a smooth transition, positioning CONMED for strong future success," said Todd Garner.

CONMED is reaffirming its full-year 2025 consolidated revenue and adjusted EPS guidance issued on November 5, 2025. Mr. Garner's planned departure is not the result of any disagreement regarding the Company's financial statements or disclosures.